Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1230, 2000-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Which drug for hypertension and diabetes?
Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. :
Which therapies warranted for postmenopausal osteoporosis?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
Preventing CMV infection - which strategy's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
Reducing the burden of congenital syphilis: which options best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 534, 2007-01 ,pp. :
Measuring indirect costs: which method's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 280, 2000-01 ,pp. :